Endovastec has repurchased a total of 1.2287 million shares, costing 129 million yuan

Zhitong
2025.09.02 08:08
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Endovastec announced that as of August 31, 2025, the company has repurchased a total of 1,228,700 shares through the centralized bidding trading method (Phase II) via the Shanghai Stock Exchange trading system, with the highest transaction price being RMB 120.00 per share, the lowest price being RMB 84.26 per share, and the total amount of funds paid being RMB 129 million (excluding stamp duty, transaction commissions, and other transaction costs)

According to the announcement from Endovastec (688016.SH), as of August 31, 2025, the company has repurchased a total of 1.2287 million shares through the centralized bidding trading method (Phase II) via the Shanghai Stock Exchange trading system. The highest repurchase price was RMB 120.00 per share, the lowest price was RMB 84.26 per share, and the total amount of funds paid was RMB 129 million (excluding transaction costs such as stamp duty and trading commissions)

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.